Wang RH

No ORCID on file · 1 paper in corpus

2025

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome.

Molecular medicine (Cambridge, Mass.) ·doi:10.1186/s10020-025-01092-x

BackgroundPolycystic ovary syndrome (PCOS) is a common gynecological disease accompanied by multiple clinical features, including anovulation, hyperandrogenism, and polycystic ovarian morphology, leading to infertility. Formononetin (FMN), …